Published in J Clin Invest on January 01, 1972
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68
Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med (1980) 5.32
Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev (2000) 4.59
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model. Infect Immun (1978) 2.46
Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates. Infect Immun (1983) 2.10
Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95
Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun (1983) 1.62
Immunization today--a review. Can Med Assoc J (1973) 1.37
Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae. Infect Immun (1978) 1.32
Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteria. Infect Immun (1975) 1.30
Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b. Infect Immun (1973) 1.27
Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev (1998) 1.26
Immunology of the infant rat experimental model of Haemophilus influenzae type b meningitis. Infect Immun (1977) 1.22
Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants. J Exp Med (1986) 1.17
Radioimmunoassay of capsular polysaccharide antigens of groups A and C meningococci and Haemophilus influenzae type b in cerebrospinal fluid. J Clin Pathol (1977) 1.07
Enzyme-linked immunosorbent assay for detection of Haemophilus influenzae type b antigen. J Clin Microbiol (1980) 1.05
Chemical composition and biological activities of a phenol-water extract from Haemophilus influenzae type a. Infect Immun (1979) 1.00
Expression of crossreactive idiotypes by human antibodies specific for the capsular polysaccharide of Hemophilus influenzae B. J Clin Invest (1988) 0.99
History of vaccination. Proc Natl Acad Sci U S A (2014) 0.98
The regulation of the immune response of mice to Haemophilus influenzae type b capsular polysaccharide. Immunology (1978) 0.97
Effectiveness of Haemophilus influenzae type b vaccines. CMAJ (1990) 0.95
A mucosal antibody response following systemic Haemophilus influenzae type B infection in children. J Clin Invest (1981) 0.90
Pathophysiology of hemolysis in infections with Hemophilus influenzae type b. J Clin Invest (1986) 0.87
Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence. J Clin Microbiol (1981) 0.85
Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b. Immunology (1989) 0.82
A glycoconjugate of Haemophilus influenzae Type b capsular polysaccharide with tetanus toxoid protein: hydrodynamic properties mainly influenced by the carbohydrate. Sci Rep (2016) 0.77
Effect of heat on antigenicity and immunogenicity of the antigenic determinant shared by Haemophilus influenzae type b and Escherichia coli K100. Infect Immun (1977) 0.75
Infectious diseases: annual review of significant publications. Postgrad Med J (1973) 0.75
Editorial: Haemophilus influenzae infections. Br Med J (1974) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med (1970) 4.90
Secondary antibody responses in haptenic systems: cell population selection by antigen. J Immunol (1967) 3.01
Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man. J Infect Dis (1970) 2.71
Polyribophosphate, the type-specific substance of Hemophilus influenzae, type b. J Biol Chem (1953) 2.24
The clinical importance of Hemophilus influenzae infections in children. Pediatr Clin North Am (1970) 1.73
Further studies on polyribophosphate. J Biol Chem (1961) 1.13
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (1985) 12.08
Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol (1999) 11.77
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell (1987) 11.56
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15
RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol (1999) 8.07
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest (1975) 7.40
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med (1978) 6.50
A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36
Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans (2002) 6.08
Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol (2000) 5.99
mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev (1993) 5.94
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (1983) 5.90
Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell (1991) 5.65
Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J Clin Microbiol (1998) 5.27
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 5.02
Transferable R factors in enteric bacteria causing infection of the genitourinary tract. Lancet (1966) 5.01
The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med (1969) 4.96
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Spontaneous tandem genetic duplications in Salmonella typhimurium arise by unequal recombination between rRNA (rrn) cistrons. Proc Natl Acad Sci U S A (1981) 4.85
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med (1999) 4.66
R factors mediate resistance to mercury, nickel, and cobalt. Science (1967) 4.57
TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J (2000) 4.41
Expression of active human factor VIII from recombinant DNA clones. Nature (1984) 4.36
Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol (1997) 4.28
Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (1983) 4.06
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut (2009) 4.06
Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1984) 3.98
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet (2001) 3.96
Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med (1984) 3.79
Marburg-virus disease in Kenya. Lancet (1982) 3.79
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74
Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol (2013) 3.72
A new kind of informational suppression in the nematode Caenorhabditis elegans. Genetics (1989) 3.69
Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood (1976) 3.34
Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33
Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31
Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J Exp Med (1976) 3.19
SMG-2 is a phosphorylated protein required for mRNA surveillance in Caenorhabditis elegans and related to Upf1p of yeast. Mol Cell Biol (1999) 3.18
Primary structure and biochemical properties of an M2 muscarinic receptor. Science (1987) 3.16
Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med (1980) 3.13
An abnormality of the alternate pathway of complement activation in sickle-cell disease. N Engl J Med (1973) 3.11
General practitioners and alternative medicine. J R Coll Gen Pract (1987) 3.10
Mode of action of novobiocin in Escherichia coli. J Bacteriol (1967) 3.09
Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis. J Pediatr (1978) 3.05
Life and death in the cytoplasm: messages from the 3' end. Curr Opin Genet Dev (1997) 3.01
Activation of a transposable element in the germ line but not the soma of Caenorhabditis elegans. Nature (1987) 3.00
The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol Cell (2000) 2.97
Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med (1980) 2.96
The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol Appl Pharmacol (1969) 2.95
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest (1987) 2.93
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92
Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities. J Biol Chem (1996) 2.89
Electron microscope observations on compounds 48-80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules. J Cell Biol (1971) 2.88
Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol (2000) 2.87
Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest (1976) 2.85
Do pili play a role in pathogenicity of Haemophilus influenzae type B? Lancet (1982) 2.84
Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74
Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest (1981) 2.66
Preclinical evaluation of a rheolytic catheter for percutaneous coronary artery/saphenous vein graft thrombectomy. J Invasive Cardiol (1999) 2.66
Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66
Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood (1996) 2.62
Increased rate of tuberculin skin test conversion among workers at a university hospital. Infect Control Hosp Epidemiol (1992) 2.60
Inhibition of protein synthesis by spectinomycin. Science (1965) 2.54
What are safe levels of alcohol consumption? Br Med J (Clin Res Ed) (1984) 2.54
Unproductively spliced ribosomal protein mRNAs are natural targets of mRNA surveillance in C. elegans. Genes Dev (2000) 2.52
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. J Immunol (1979) 2.47
Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45
The costs of treating COPD in the United States. Chest (2001) 2.43
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci (1992) 2.41
The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J (1987) 2.39
Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A (1992) 2.38
Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology (1980) 2.35
Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b. J Pediatr (1972) 2.33
Transposition of Tc1 in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1985) 2.33
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. Lancet (1975) 2.31
Studies on the epidemiology of resistance (R) factors. I. Analysis of Klebsiella isolates in a general hospital. II. A prospective study of R factor transfer in the host. Ann Intern Med (1969) 2.28
Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci (2001) 2.28
Recovery of resistance (R) factors from a drug-free community. Lancet (1969) 2.26
Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase. Infect Immun (1974) 2.26
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A (1991) 2.24